The analysis included trials in which adults with confirmed cancer received structured exercise as part of their care and that reported survival or recurrence outcomes. Breast cancer was the most frequently studied cancer, followed by bowel and pancreatic cancer. Overall, participants assigned to exercise were 23% less likely to die and 17% less likely to experience a recurrence before death than those in comparison groups. Separate analyses indicated an 18% lower risk of death from any cause and a 26% lower risk of death from cancer among participants who exercised. These results were reported as statistically significant improvements in overall survival, although the review’s broader limitations include substantial differences among the programmes in exercise type, duration and intensity.

The evidence did not clearly show that structured exercise extended the period before cancer progression or increased the probability that no invasive cancer remained after standard treatment. An exploratory analysis suggested that associations were stronger among participants who completed at least 70% of their prescribed exercise programme, indicating that adherence may be relevant to the observed outcomes. Estimates also favoured aerobic exercise on its own and programmes combining aerobic exercise with strength training. No clear association was found for strength training alone, but that conclusion was based on only one trial involving 129 participants and therefore remains uncertain. The analysis was not designed to establish the optimal type, dose or intensity of exercise for every cancer diagnosis.

The researchers proposed several plausible mechanisms that could help explain the findings, while distinguishing these biological explanations from the clinical evidence. Aerobic exercise may condition the cardiovascular system, mobilise immune cells and normalise blood flow within tumours, all processes relevant to systemic tumour control. Other proposed effects include an enhanced immune response to cancer, reduced circulating levels of sex-specific hormones, greater glucose uptake by muscles that leaves less glucose available to fuel cancer cells, and improved repair of DNA damage that could otherwise contribute to more aggressive tumour behaviour. These mechanisms remain potential pathways rather than directly demonstrated causes of the survival associations observed in the meta-analysis.

Several features limit how confidently the results can be applied across the wider population of people with cancer. Participants in comparison groups may have adopted healthier behaviours during follow-up, potentially influencing the measured differences. The included interventions also varied considerably, while most of the evidence came from breast cancer trials and relatively little addressed advanced-stage disease. In addition, 88% of participants were women, and the average participant age of 54 may restrict generalisation to other demographic groups. The researchers concluded that the evidence supports considering the potential role of structured exercise within oncological care, but they stressed that the effects were context-dependent and sensitive to trial design, conduct and feasibility. They also noted that ongoing trials are needed to define how exercise can most appropriately be incorporated into cancer treatment pathways and which patients are most likely to benefit.

Subject of Research: Associations between structured exercise programmes, overall survival and cancer recurrence in randomised clinical trials.

Article Title: Structured exercise linked to longer cancer survival and time free of disease

Article References: Structured exercise linked to longer cancer survival and time free of disease. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: structured exercise, cancer survival, cancer recurrence, aerobic exercise, strength training, systematic review, meta-analysis, randomised trials, exercise adherence, oncological care, Structured, exercise